ICICI Pru Healthcare Fund

The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.

Growthvine rating: 5/5 — ranked #3 of 87 in category.

Fund basics

CategoryEquity: Sectoral
NAV₹44.27 (as of 2026-11-13)
AUM₹7,104 Cr
Expense ratio1.54%
RiskometerVery High
Fund managerDharmesh Kakkad
Exit load1% for redemption within 15 days

Performance & risk

5-year annualised return15.51%
Sharpe ratio0.95
Standard deviation16.16%
Max drawdown−20.72%
Alpha-0.83
Beta0.96

Over 5 years, captured 93.0% of NIFTY Pharma's upside and 84.5% of its downside.

Market cap allocation

Large cap24.9%
Mid cap32.0%
Small cap43.1%

Concentration

Top 5 holdings35.9%
Top 10 holdings56.7%
Total holdings39

Top holdings

Top sectors

Calendar-year track record

YearReturnQuartileCategory rank
2026 (partial)11.2%Q2#20 of 76
2025−0.8%Q3#37 of 69
202448.1%Q1 (Top)#2 of 58
202341.3%Q2#15 of 48
2022−8.5%Q4 (Bottom)#36 of 46